The Mtech Access team reflect on a energising and inspiring ISPOR Europe – with commentary from top 10 influencer Prof Phil Richardson
Read More
In the field of systematic reviews and evidence synthesis, strong, multi-partner teams are critical for moving new drugs from early development and testing in the lab to treating people in…
Hannah Baker (Health Economics Consultant) tells us about joining Mtech Access to gain experience with wider market access services
We are delighted to announce that we will be exhibiting at ISPOR Europe from 7th–9th November 2022 in Vienna, Austria. ISPOR Europe is probably the most anticipated HEOR conference of...
Read More
Inspired by the oral presentations and panel discussions at the recent HTAi Conference in Utrecht, The Netherlands, Persefoni Ioannou (Consultant – Health Technology Assessment [HTA]) shares some key trends in...
Read More
The National Institute for Health and Care Excellence (NICE) has published updated manuals for methods, processes and topic selection for Health Technology Assessments (HTA). This includes changes to how NICE...
Read More
In this webinar, we explored the challenges facing orphan medicines and other innovative rare disease treatments looking to achieve market access in Europe. Orphan medicines and rare disease treatments are...
Read More
On World Evidence-Based Healthcare Day (20th October 2021), we explore the role of evidence in an infodemic and how evidence generation processes have been accelerated to offer rapid yet robust...
Read More
Finding, bringing together and synthesising a comprehensive evidence base is a key part of the reimbursement process and the wider market access journey for pharmaceutical products. This evidence generation process...
Read More
Janine Ross, who recently joined the Mtech Access evidence team as a Consultant Information Scientist, explains how her aptitude for searching and identifying evidence data has earned her the nickname...
Read More
